Clinical Evaluation of Subperiosteal Tunneling Technique with Bone Graft and Platelet-Rich Fibrin for Horizontal Ridge Augmentation

Clinical Evaluation of Subperiosteal Tunneling Technique with Bone Graft and Platelet-Rich Fibrin for Horizontal Ridge Augmentation - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111605

Enrollment

Registered

2026-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Minimally Invasive Horizontal Ridge Augmentation using Bone Graft: A minimally invasive subperiosteal tunneling approach will be utilized for horizontal ridge augmentation while preserv

Eligibility

Inclusion criteria

Inclusion criteria: atients aged 18to60 years Horizontal ridge deficiency requiring augmentation Bone defect less then 1.5 cm Medically fit patients Willing for surgery and follow-up Written informed consent obtained

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Systemic disease affecting healing Bleeding disorders Active oral infection or malignancy Known drug allergy Unwilling for participation or follow-up

Design outcomes

Primary

Measure	Time frame
Primary Outcome Increase in horizontal alveolar ridge width following augmentation. Timepoint: NIL	—

Secondary

Measure	Time frame
secondary Outcomes Improvement in bone density on CBCT evaluation. Enhanced soft tissue healing. Reduced postoperative pain & complications. Successful implant site development & implant feasibility.Timepoint: 3 month & 6 month	—

Countries

India

Contacts

Public ContactDr YOGITA JANGALE

Hitkarini Dental College and Hospital

yogitajangale9@gmail.com7389392333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026